Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
8.21
-0.03 (-0.36%)
At close: Sep 11, 2026, 4:00 PM EDT
8.26
+0.05 (0.61%)
After-hours: Sep 11, 2026, 7:59 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $1.41 billion as of September 11, 2026. Its market cap has increased by 295.92% in one year.
Market Cap
1.41B
Enterprise Value
1.21B
1-Year Change
295.92%
Ranking
Category
Stock Price
$8.21
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.41B, an increase of 232.93%. That is a compound annual growth rate of 26.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.41B | 168.48% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalyn Pharma | 1.49B |
| Innoviva | 1.48B |
| Ascentage Pharma Group International | 1.47B |
| Latigo Biotherapeutics | 1.47B |
| LB Pharmaceuticals | 1.44B |
| ArriVent BioPharma | 1.43B |
| Ultragenyx Pharmaceutical | 1.41B |
| Maze Therapeutics | 1.37B |